Mechanistically we show that the CaMKK2-AMPK axis controls the survival and the terminal differentiation of tumor-induced MDSCs by fine-tuning the accumulation of reactive oxygen species (ROS). The gene discussed is CAMKK2; the disease is neoplasm.